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ABSTRACT
INTRODUCTION Patients who are Jehovah’s Witnesses pose difficult ethical and moral dilemmas for surgeons because of their
refusal to receive blood and blood products. This article outlines the personal experiences of six Jehovah’s Witnesses who
underwent major abdominal surgery at a single institution and also summarises the literature on the perioperative care of these
patients.
METHODS The patients recorded their thoughts and the dilemmas they faced during their surgical journey. We also reviewed
the recent literature on the ethical principles involved in treating such patients and strategies recommended to make surgery
safer.
RESULTS All patients were supported in their decision making by the clinical team and the Hospital Liaison Committee for
Jehovah’s Witnesses. The patients recognised the ethical and moral difficulties experienced by clinicians in this setting.
However, they described taking strength from their belief in Jehovah. A multitude of techniques are available to minimise the
risk associated with major surgery in Jehovah’s Witness patients, many of which have been adopted to minimise unnecessary
use of blood products in general. Nevertheless, the risks of catastrophic haemorrhage and consequent mortality remain an
unresolved issue for the treating team.
CONCLUSIONS Respect for a patient’s autonomy in this setting is the overriding ethical principle, with detailed discussion form-
ing an important part of the preparation of a Jehovah’s Witness for major abdominal surgery. Clinicians must be diligent in the
documentation of the patient’s wishes to ensure all members of the team can abide by these.
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Jehovah’s Witness is a Christian movement started in 1872 by
Charles Taze Russell with a global following of over 7.8 mil-
lion. An integral tenet of the belief of Jehovah’s Witnesses is
their refusal to accept allogenic whole blood and its four
main components: red and white blood cells, platelets and
plasma. They believe that the storage, consumption or trans-
fusion of blood and related products is prohibited by Biblical
passages, which they feel clearly command abstinence from
eating or consuming blood (Table 1). Consequently, Jeho-
vah’s Witnesses believe that avoiding blood transfusions rep-
resents not only obedience to God but also a mark of respect.1
The medical and legal challenges facing clinicians treat-
ing Jehovah’s Witnesses have been explored,2–4 and reports
of successful blood conserving techniques in abdominal
surgery have been published.5–8 However, neither the
patients’ own perspectives nor the spiritual, psychological
and emotional dilemmas that they encounter have been
documented. Six adult Jehovah’s Witnesses who underwent
major abdominal (pancreaticobiliary) surgery shared their
thoughts and experiences through letters and personal
communication. We also suggest strategies that could help
make major elective surgery safe in such patients.
Ethical principles
There is a range of complex issues relating to the four main
ethical principles9 involved when Jehovah’s Witnesses
refuse blood transfusion. The principle of autonomy should
be respected in patients who can provide informed consent
and do not wish to receive blood products,10 even if the clini-
cian feels that this is an irrational decision11 or that it may
lead inevitably to the death of the patient, which can be
incredibly difficult for a physician to accept.12
On the other hand, the principle of non-maleficence
mandates that physicians should avoid harm for their
patients and as such, the act of withholding blood products
(albeit an act of omission) can cause internal conflict to
physicians in this situation. In a similar concept, the princi-
ple of beneficence supports the physician in treating the
patient to the maximum benefit, which may in some cases
be by the transfusion of blood products.
However, when the patients’ beliefs are taken into consid-
eration (that should they receive blood products, this will be
seriously damaging to their relationship with their god), it
becomes more feasible to understand the counterargument.
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The final principle of justice supports honouring a compe-
tent patient’s wishes. Consequently, withholding blood prod-
ucts is justifiable in this context.
Clinical considerations
The reluctance to use whole blood and its main fractions
(both by Jehovah’s Witnesses and on rare occasions when
other individuals prefer to avoid blood transfusions) has
spurred the development of perioperative protocols to
improve patients’ haematological markers, including hae-
moglobin prior to surgery, and to conserve blood during
surgery (Table 2).13–23 There is variability in the products
deemed unacceptable by Jehovah’s Witnesses and the
acceptability of products should be established prior to any
intervention.4
Products that are generally acceptable include recombi-
nant erythropoietin, recombinant factor VIIa and artificial
Table 1 Biblical passages related to consumption of blood
Book, chapter and verse Passage
Genesis 9:4 Only flesh with its life – its blood – you must not eat.
Leviticus 17:10 If any man of the house of Israel or any foreigner who is residing in your midst eats any sort of blood,
I will certainly set my face against the one who is eating the blood, and I will cut him off from among his people.
Deuteronomy 12:23 Just be firmly resolved not to eat the blood, because the blood is the life, and you must not eat the life with the
flesh.
Acts 15:28, 29 For the Holy Spirit and we ourselves have favoured adding no further burden to you except these necessary things:
to keep abstaining from things sacrificed to idols, from blood, from what is strangled, and from sexual immorality.
If you carefully keep yourselves from these things, you will prosper. Good health to you!
Leviticus 17:14 For the life of every sort of flesh is its blood, because the life is in it. Consequently, I said to the Israelites:
‘You must not eat the blood of any sort of flesh because the life of every sort of flesh is its blood. Anyone
eating it will be cut off.’
Table 2 Perioperative strategies for minimising risk in major surgery in Jehovah’s witnesses (adapted from Care Plan for Surgery in
Jehovah’s Witnesses, available from http://www.transfusionguidelines.org/document-library/documents/care-plan-for-surgery-in-jeho-
vahs-witnesses-leaflet/)
Preoperative Intraoperative Postoperative
Correct anaemia
Oral or intravenous iron
Folic acid
Vitamin B12
Minimise blood sampling
Treat menorrhagia
Erythropoietin stimulating agents13
Correct clotting abnormalities
Review non-steroidal anti-inflammatory
agents, warfarin, antibiotics
Vitamin K14
Protamine
Consider haemostatic agents
Check coagulation profile
Techniques to minimise blood loss
Meticulous haemostasis
Haemostatic dissecting devices
Radiologically guided arterial occlusion15
Minimally invasive procedures
Extended surgical team
Surgical positioning16
Staging of complex procedures
Alternatives to blood transfusion
Intraoperative cell salvage*17
Artificial oxygen carriers (haemoglobin-based or
perfluorocarbon-based)18
Anaesthetic techniques
Hypotensive anaesthesia
Normovolaemic / hypervolaemic haemodilution*19
Full patient monitoring (eg thromboelastography)
Maintain normothermia20
Haemostatic agents
Topical (surgical adhesives, sealants)*21
Injectable (tranexamic acid, desmopressin,
vitamin K)21
Other (cryoprecipitate, prothrombin complex,
vasopressin)*
Cell salvage
Wound drainage and collection
for retransfusion*22
Anaemia
Oxygen support
Erythropoietin stimulating agents
Intravenous iron
Folic acid
Vitamin B12
Minimise phlebotomy
Hyperbaric oxygen23
For bleeding
Radiologically guided arterial
occlusion
Prompt reoperation
Direct pressure
Haemostatic agents
Tourniquet
Controlled hypotension
For shock
Trendelenburg position
Medical antishock trousers
Monitoring and observation
Enhanced schedule for early
detection of haemorrhage
*Dependent on patient preference
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blood substitutes whereas those that may be acceptable
include platelet fractions, albumin, immunoglobulins, cryo-
precipitate, interferons and red cell fractions including
human haemoglobin. Artificial blood substitutes work to
mimic some of the biological functions of red blood cells
(most notably that of oxygen and carbon dioxide), and are
most commonly seen as haemoglobin-based oxygen car-
riers and perfluorocarbon-based oxygen carriers.18 How-
ever, these are not readily available for clinical use.
Preoperative optimisation of patients who are Jehovah’s
Witnesses (especially those with anaemia) may be
achieved using intravenous iron infusions and erythropoie-
tin stimulating agents to augment erythropoiesis.24 This is
a slow process and needs to be implemented several weeks
before surgery to gain maximal benefit. Anaemia should
be corrected, as far as possible, preoperatively as decreas-
ing preoperative haemoglobin concentrations are associ-
ated with increased morbidity and mortality in such
patients.25,26
Intraoperative measures include cell salvage of blood
loss and acute normovolaemic haemodilution to minimise
red cell loss. Some patients will accept these techniques
while others will refuse. All our patients were happy to
accept cell salvaged blood, irrespective of the potential risk
of retransfusing malignant cells.27 Recent literature, how-
ever, suggests that the use of cell salvage does not increase
the risk of cancer recurrence,28,29 which may further
encourage patients to accept this strategy for perioperative
blood management.
A number of anaesthetic and surgical strategies for the
minimisation of blood loss4 have been identified previously.
Anaesthetic strategies include ventilation designed to reduce
venous preload and, therefore, any potential increase in
bleeding, temperature regulation to ensure that patients do
not develop hypothermia and resultant coagulopathy,19 and
patient positioning (typically in the Trendelenburg posi-
tion).16 Intraoperative surgical strategies include the use of
electrosurgery devices to assist with meticulous haemosta-
sis, direct compression to achieve haemostasis, the applica-
tion of haemostatic agents such as fibrin glues, gelatine-
based sealants and human fibrinogen packs, and the use
of tourniquets in limb surgery.30 The Association of Anaes-
thetists of Great Britain and Ireland31 and The Royal College
of Surgeons of England32 have also published guidelines
that outline measures to minimise risk in Jehovah’s Wit-
nesses who undergo major surgery.
Strategies to minimise postoperative blood loss include
prompt assessment by a senior clinician if acute blood loss
is suspected, the rationalisation of postoperative phlebot-
omy and use of paediatric tubes where available. In certain
surgical specialties, postoperative wound drainage systems
have been designed to allow the autotransfusion of drained
blood, minimising any loss, although the evidence for this
is contradictory.22,33 Other techniques for patients who
have experienced severe intraoperative blood loss include
hyperbaric23 and extracorporeal oxygen therapy34 but
these are not in widespread use.
Extensive preoperative discussions involving the respon-
sible anaesthetist, surgeon and all our patients were
undertaken to ensure a firm understanding of the diagno-
sis, prognosis, operative challenges and potential problems.
The patients also received guidance from the Hospital Liai-
son Committee for Jehovah’s Witnesses to help guide their
decision making, including a suggested care plan and
advance directives. This support network is available 24
hours a day generally via the local hospital switchboard.
However, patient consent must be obtained prior to involv-
ing this body. Further information for both patients and
clinicians is also available.35
A thorough briefing with the entire theatre team before
commencing the operation is essential. All operative strat-
egies and any contingency plans necessary for the safe
conduct of the operation should be clarified, and criteria
for terminating the procedure in the event of intraopera-
tive problems should be discussed at the briefing. A debrief
should also be conducted with the team at the end of the
operation and postoperative strategies should be docu-
mented clearly in the case notes. All personnel (including
nursing and support staff) involved in the postoperative
care of these patients should be made aware of the
patient’s wishes and the postoperative monitoring and
treatment plan.
Our patients
The six patients in our series were aged between 23 and
77 years. All but one were female. Four patients underwent
a pancreaticoduodenectomy for cancer, one underwent a
hepaticojejunostomy for recurrent common bile duct
stones related to cystic fibrosis, and one had biliary and
gastric bypass surgery for locally advanced pancreatic
cancer.
They were all given clear advice about the risk of under-
going major surgery without using blood transfusion as
well as information regarding the alternatives available.
Patients were also given the opportunity to review and dis-
cuss an advance directive (Fig 1), which stipulates which
products they find acceptable for transfusion on an individ-
ual basis prior to surgery. The aim was to enable them to
make an informed choice of whether to opt for surgery,
bearing in mind the risks and potential problems.
Three patients had preoperative anaemia (haemoglobin
79–117g/l) and underwent optimisation prior to surgery
using intravenous iron and/or erythropoietin stimulating
agents (post-treatment haemoglobin 121–127g/l). All
patients provided consent for intraoperative cell salvage
but as the blood loss was <500ml in each case, the need for
the transfusion of salvaged blood did not arise. The
patients made uneventful recoveries and were discharged
on postoperative days 5–13 on oral iron therapy.
Patients’ perspectives
From the outset of their surgical journey, all our patients
had refused transfusion of whole blood or its major frac-
tions, regardless of the medical consequences. Accepting
the diagnosis of a life threatening disease is difficult
enough but for Jehovah’s Witnesses, there are added
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concerns as the potential treatments offered may pose an
even greater threat to their lives. One of the initial con-
cerns that most patients recount is that their refusal to
receive blood transfusion may exclude them from being
offered potentially curative but extensive surgery. One
patient wrote: ‘Refusal to accept blood transfusions clashed
with what doctors thought to be in the best interests. […] I
was not sure I would be offered an operation (Whipple’s)
[…] my only chance of cure […] frightening […] my refusal
to accept blood transfusions meant […] I could die.’
Another patient reported: ‘My first thought was that I can’t
change anything so I prayed hard […] gave me the courage to
cope with my situation.’ She felt that ‘for me to go against
God’s guidance would render my 36 years as a Witness a lie’.
All patients felt that their faith helped them and their
families to make the decision to opt for surgical interven-
tion, and also to cope if faced with a life threatening situa-
tion. They felt that their concerns were well understood
and respected. This gave them confidence and made the
decision making process easier. The Hospital Liaison Com-
mittee for Jehovah’s Witnesses was another source of
advice and guidance that patients found very useful. They
were provided with up-to-date literature regarding alterna-
tives to transfusion during the perioperative period, which
helped them make appropriate choices that were in keep-
ing with their religious beliefs.
The patients also appreciated the dilemma the clinicians
had. One wrote: ‘I know how difficult it would have been
for yourself and your team if things went wrong and you
were forced to allow me to die, when all your years of
training has been to do all in your power to sustain life!’
Another patient stated: ‘My religious beliefs as a Jehovah’s
Witness are very sincere and I was aware due to my refusal
to accept blood products that this may cause concern to
those involved in the surgery.’
One patient summarised the general feeling among all the
patients in our series: ‘People would perhaps ask the question
“What if matters became critical and a blood transfusion was
the only option?” However, if that were to be the case, along
with my absolute faith that my integrity to my God Jehovah
would be rewarded, I have to say that I had no major doubts
due to the knowledge I had and also the expertise of the medi-
cal team conducting my operation. I feel a great debt to all of
them and will do so for the rest of my life.’
Clinicians’ perspectives
The unpredictability of blood loss during the course of
major surgery poses a daunting prospect to the clinicians
involved in the care of patients who are Jehovah’s Wit-
nesses. Although preoperative anaemia can be corrected
relatively easily nowadays and cell salvage is a useful
adjunct, not all patients consent to cell salvage.36 Excessive
blood loss in the absence of the facility for cell salvage can
be life threatening and most patients agree that in this sit-
uation, it would be prudent to truncate the operation rather
than proceed to heroic resections that would result in a
high risk of mortality.
In addition, the development of postoperative complica-
tions (especially haemorrhagic ones) could prove life
Figure 1 Advance decision document for Jehovah’s Witnesses (reproduced with permission of the Hospital Information Services for Jeho-
vah’s Witnesses, London)
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threatening and difficult to manage without the use of
blood products. Patients with a postoperative haemoglobin
concentration of <70g/l are known to have a progressive
increase in overall mortality rates.37 This should be
avoided if at all possible and treated rapidly using estab-
lished adjuncts when necessary.38 Despite this, there are
documented cases of patient survival without any signifi-
cant sequelae even with extremely low postoperative hae-
moglobin levels.39,40
The decision to offer Jehovah’s Witnesses major surgery
is potentially more difficult in those with benign disease
than in those who have cancer as in the former group, the
disease is unlikely to result in death while the operation
may. However, patients usually accept the increased risks
if they understand that they will be cared for by a team
that is used to managing Jehovah’s Witnesses. Neverthe-
less, it can prove a traumatic experience for the treating
team41 to lose a patient because of haemorrhage that can-
not be managed with the transfusion of blood and blood
products.
Conclusions
The prospect of having to undergo major surgery can be
challenging for Jehovah’s Witnesses as well as for the
clinicians treating them. However, the wishes of the patient
are paramount in the clinical decision making processes.
Clinicians must be diligent in the documentation of the
patient’s wishes to ensure all members of the team can
abide by these. A multitude of techniques are available to
reduce the risk associated with undertaking major surgery
in patients who are Jehovah’s Witnesses, many of which
are becoming more widely adopted to minimise use of
unnecessary blood products in general clinical care.
Although major surgery can often be performed safely in
these patients, the risks of catastrophic haemorrhage and
consequent mortality remain an unresolved issue for the
treating team.
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